Thermo Fisher Scientific Inc. (TMO) Earnings History
Profitable37 years of earnings data (1989–2025) · Positive TTM net income
Loading earnings history...
Thermo Fisher Scientific Inc. (TMO) Earnings Overview
As of June 21, 2026, Thermo Fisher Scientific Inc. (TMO) reported trailing twelve-month net income of $6.86B, reflecting +7.3% year-over-year growth. The company earned $18.39 per diluted share over the past four quarters, with a net profit margin of 15.1%.
Looking at the long-term picture, TMO's 5-year EPS compound annual growth rate (CAGR) stands at +2.1%, reflecting modest earnings expansion. The company achieved its highest annual net income of $7.72B in fiscal 2021.
Thermo Fisher Scientific Inc. maintains industry-leading profitability with a gross margin of 37.7%, operating margin of 18.2%, and net margin of 15.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including DHR ($3.69B net income, 14.7% margin), A ($1.41B net income, 18.8% margin), WAT ($449M net income, 20.3% margin), TMO has outperformed on profitability metrics. Compare TMO vs DHR →
TMO Earnings vs Peers
Earnings metrics vs comparable public companies
TMO Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.74B | +6.3% | $8.11B | $17.74 | 15.1% | 18.2% |
| 2024 | $6.33B | +5.7% | $7.66B | $16.53 | 14.8% | 17.9% |
| 2023 | $6.00B | -13.7% | $7.45B | $15.45 | 14.0% | 17.4% |
| 2022 | $6.95B | -10.0% | $8.53B | $17.64 | 15.5% | 19.0% |
| 2021 | $7.72B | +21.2% | $10.32B | $19.46 | 19.7% | 26.3% |
| 2020 | $6.38B | +72.5% | $7.90B | $15.98 | 19.8% | 24.5% |
| 2019 | $3.70B | +25.8% | $4.26B | $9.17 | 14.5% | 16.7% |
| 2018 | $2.94B | +32.0% | $3.87B | $7.24 | 12.1% | 15.9% |
| 2017 | $2.23B | +10.1% | $3.27B | $5.59 | 10.6% | 15.6% |
| 2016 | $2.02B | +2.3% | $2.86B | $5.09 | 11.1% | 15.6% |
| 2015 | $1.98B | +4.3% | $2.49B | $4.92 | 11.6% | 14.7% |
| 2014 | $1.89B | +48.8% | $2.35B | $4.71 | 11.2% | 13.9% |
| 2013 | $1.27B | +8.1% | $1.80B | $3.48 | 9.7% | 13.7% |
| 2012 | $1.18B | -11.4% | $1.63B | $3.21 | 9.4% | 13.0% |
| 2011 | $1.33B | +28.4% | $1.48B | $3.46 | 11.3% | 12.6% |
| 2010 | $1.04B | +21.8% | $1.26B | $2.53 | 9.6% | 11.7% |
| 2009 | $850M | -14.5% | $1.12B | $2.01 | 8.4% | 11.1% |
| 2008 | $994M | +30.6% | $1.27B | $2.25 | 9.5% | 12.1% |
| 2007 | $761M | +350.5% | $1.07B | $1.72 | 7.8% | 10.9% |
| 2006 | $169M | -24.3% | $365M | $0.84 | 4.5% | 9.6% |
| 2005 | $223M | -38.3% | $294M | $1.36 | 8.5% | 11.2% |
| 2004 | $362M | +80.9% | $254M | $2.17 | 16.4% | 11.5% |
| 2003 | $200M | -35.4% | $185M | $1.20 | 9.5% | 8.8% |
| 2002 | $310M | +39758.1% | $155M | $1.73 | 14.8% | 7.5% |
| 2001 | $-781,000 | +97.8% | $34M | $-0.00 | -0.0% | 1.6% |
| 2000 | -$36M | +79.3% | $198M | $-0.22 | -1.6% | 8.7% |
| 1999 | -$175M | -196.0% | $249M | $-1.10 | -7.1% | 10.1% |
| 1998 | $182M | -24.0% | $376M | $1.08 | 4.7% | 9.7% |
| 1997 | $239M | +25.4% | $407M | $1.41 | 6.7% | 11.4% |
| 1996 | $191M | +36.2% | $284M | $1.22 | 6.5% | 9.7% |
| 1995 | $140M | +35.5% | $247M | $0.99 | 6.3% | 11.2% |
| 1994 | $103M | +35.0% | $180M | $0.82 | 6.5% | 11.3% |
| 1993 | $77M | +29.4% | $124M | $0.29 | 6.1% | 9.9% |
| 1992 | $59M | +25.7% | $68M | $0.17 | 6.2% | 7.2% |
| 1991 | $47M | +38.9% | $38M | $0.16 | 5.8% | 4.8% |
| 1990 | $34M | +37.8% | $36M | $0.13 | 4.8% | 5.0% |
| 1989 | $25M | - | $18M | $0.10 | 4.2% | 3.1% |
Download Data
Export TMO earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into TMO consensus models and risk factors.
Should I Buy TMO?
Wall Street verdict, signals, and target summaries.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TMO — Frequently Asked Questions
Quick answers to the most common questions about buying TMO stock.
What is TMO earnings per share (EPS)?
TMO trailing twelve-month (TTM) diluted EPS is $18.39, reflecting +7.3% year-over-year growth. The 5-year EPS CAGR is +2.1%. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is Thermo Fisher Scientific Inc.'s net income?
Thermo Fisher Scientific Inc. (TMO) trailing twelve-month net income is $6.9B as of 2025. Earnings grew +7.3% year-over-year. Thermo Fisher Scientific Inc. has been profitable for 24 consecutive years.
Is TMO profitable?
Yes, TMO is profitable with a TTM net income of $6.9B and a net profit margin of +15.1%. Thermo Fisher Scientific Inc. has generated profits for 24 consecutive years.
What is TMO's earnings growth rate?
TMO compound annual EPS growth rates (CAGR): 1-Year: +7.3%, 3-Year: +0.2%, 5-Year: +2.1%, 10-Year: +13.7%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are TMO's profit margins?
Thermo Fisher Scientific Inc. net profit margin is +15.1%, operating margin is +18.2%, and gross margin is +37.7%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +13.1%.
Is TMO growing earnings?
TMO is growing earnings steadily. YoY EPS growth of +7.3% is consistent with the 5-year CAGR of +2.1%. TTM net income is $6.9B.
What was TMO's best earnings year?
Thermo Fisher Scientific Inc.'s highest annual net income on record is $7.7B, achieved in fiscal year 2021. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were TMO's earnings last quarter?
TMO's most recent reported quarter was Q1 2026. Net income was $1.7B with diluted EPS of $4.43. For a full breakdown of all quarters, see the quarterly earnings table on this page.